APP and Alzheimer disease: The hyperphosphorylation of CRMP2 at specific residues is observed in AD brains [41,42,43,44,45] and AD mouse models (APP/PS1 and Tg2576 mice [43,45,46,86]), suggesting its involvement in early AD events [43].